Validations: Performance KPIs, Audits & Remediation
Remote/Hybrid Audits: Tools, Evidence, and Security The pharmaceutical industry has increasingly turned to remote or hybrid audit solutions in the wake of the COVID-19 pandemic and the ongoing need for effective oversight of suppliers, Contract Manufacturing Organizations (CMOs), and Contract Development and Manufacturing Organizations (CDMOs). This guide provides a comprehensive overview of the tools, evidence requirements, and security considerations associated…
Audit Closure Metrics: On-Time and Effectiveness Audit Closure Metrics: On-Time and Effectiveness Effective management of audits in the pharmaceutical industry is critical to ensure quality compliance and enhance supplier engagement. This article provides a detailed step-by-step guide on audit closure metrics, focusing on on-time delivery and effectiveness, aiming to assist pharma professionals in managing validation and oversight processes efficiently. 1….
Risk Heatmaps for Oversight: Visualizing Exposure Risk Heatmaps for Oversight: Visualizing Exposure Introduction to Risk Heatmaps in Pharmaceutical Oversight In the pharmaceutical industry, particularly in the context of supplier, CMO/CDMO, and tech-provider oversight, realizing the importance of systematic risk management is foundational. A risk heatmap serves as a cognitive tool for professionals to visually assess potential risks associated with suppliers…
Regulatory Inspection Histories: What to Ask and Verify In the complex landscape of the pharmaceutical industry, ensuring the quality and compliance of suppliers, Contract Manufacturing Organizations (CMOs), and technology providers is paramount. Regulatory requirements such as those imposed by the FDA, EMA, and MHRA, necessitate a thorough examination of vendors prior to and during any partnership. This article provides a…
KPI Dashboards for Governance Meetings KPI Dashboards for Governance Meetings In the highly regulated pharmaceutical industry, effective oversight of suppliers and Contract Manufacturing Organizations (CMOs) is essential for ensuring quality and compliance. As part of this oversight, establishing comprehensive KPI dashboards is vital for governance meetings. This step-by-step tutorial will guide pharmaceutical professionals through the process of developing and utilizing…
Escalation Trees to Executive Review Escalation Trees to Executive Review In the complex landscape of pharmaceutical manufacturing, ensuring the integrity of processes and compliance with stringent regulations is paramount. The oversight of suppliers, Contract Manufacturing Organizations (CMOs), and Contract Development and Manufacturing Organizations (CDMOs) requires a robust framework to monitor performance, validate deliverables, and maintain quality agreement clauses. This guide…
OTIF vs OTD: Which KPI Matters and When OTIF vs OTD: Which KPI Matters and When Understanding key performance indicators (KPIs) is essential for pharmaceutical professionals managing supplier relationships and contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). Among the various KPIs in use, On-Time In-Full (OTIF) and On-Time Delivery (OTD) are often compared—each with distinct implications…
Supplier Deviation Trending: From Pareto to CAPA In the complex landscape of pharmaceutical manufacturing, managing supplier deviations is paramount for ensuring compliance and safeguarding product quality. This article provides a comprehensive step-by-step tutorial aimed at pharma professionals, covering the intricacies involved in trending supplier deviations from Pareto analysis to effective CAPA (Corrective and Preventive Action) systems. With regulatory expectations set…
For-Cause Audits: Triggers and Preparation For-Cause Audits: Triggers and Preparation The pharmaceutical industry is governed by stringent regulatory expectations, with oversight being a critical component in ensuring compliance and maintaining product quality. For-cause audits are essential when there is reason to believe that a supplier, contract manufacturing organization (CMO), or contract development and manufacturing organization (CDMO) is failing to meet…
Remediation Plans: Structure, Timelines, and Follow-Up Remediation Plans: Structure, Timelines, and Follow-Up In the pharmaceutical industry, remediation plans are essential in addressing deficiencies identified during vendor audits, performance evaluations, or regulatory inspections. These plans facilitate quality assurance by ensuring compliance with regulatory expectations and continuously improving supply chain performance. This guide will walk you through the comprehensive steps to develop…